SKYE logo

Skye Bioscience (SKYE) Stock

Profile

Full Name:

Skye Bioscience, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

26 November 2014

Indexes:

Not included

Description:

Skye Bioscience is a biotechnology company focused on developing cannabinoid-based therapies for various medical conditions, aiming to improve patient outcomes through innovative treatments.

Events Calendar

Earnings

Next earnings date:

May 08, 2025

Recent quarterly earnings:

Nov 07, 2024

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Sept 08, 2023

Analyst ratings

Recent major analysts updates

30 Sept '24 Scotiabank
Sector Outperform
20 Sept '24 Piper Sandler
Overweight
20 Sept '24 Cantor Fitzgerald
Overweight
10 Sept '24 JMP Securities
Market Outperform
09 Sept '24 Cantor Fitzgerald
Overweight
06 Sept '24 Cantor Fitzgerald
Overweight
27 Aug '24 Cantor Fitzgerald
Overweight
09 July '24 Craig-Hallum
Buy
01 July '24 Cantor Fitzgerald
Overweight
18 June '24 Cantor Fitzgerald
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

FAQ

  • What is the primary business of Skye Bioscience?
  • What is the ticker symbol for Skye Bioscience?
  • Does Skye Bioscience pay dividends?
  • What sector is Skye Bioscience in?
  • What industry is Skye Bioscience in?
  • What country is Skye Bioscience based in?
  • When did Skye Bioscience go public?
  • Is Skye Bioscience in the S&P 500?
  • Is Skye Bioscience in the NASDAQ 100?
  • Is Skye Bioscience in the Dow Jones?
  • When was Skye Bioscience's last earnings report?
  • When does Skye Bioscience report earnings?
  • Should I buy Skye Bioscience stock now?

What is the primary business of Skye Bioscience?

Skye Bioscience is a biotechnology company focused on developing cannabinoid-based therapies for various medical conditions, aiming to improve patient outcomes through innovative treatments.

What is the ticker symbol for Skye Bioscience?

The ticker symbol for Skye Bioscience is NASDAQ:SKYE

Does Skye Bioscience pay dividends?

No, Skye Bioscience does not pay dividends

What sector is Skye Bioscience in?

Skye Bioscience is in the Healthcare sector

What industry is Skye Bioscience in?

Skye Bioscience is in the Biotechnology industry

What country is Skye Bioscience based in?

Skye Bioscience is headquartered in United States

When did Skye Bioscience go public?

Skye Bioscience's initial public offering (IPO) was on 26 November 2014

Is Skye Bioscience in the S&P 500?

No, Skye Bioscience is not included in the S&P 500 index

Is Skye Bioscience in the NASDAQ 100?

No, Skye Bioscience is not included in the NASDAQ 100 index

Is Skye Bioscience in the Dow Jones?

No, Skye Bioscience is not included in the Dow Jones index

When was Skye Bioscience's last earnings report?

Skye Bioscience's most recent earnings report was on 7 November 2024

When does Skye Bioscience report earnings?

The next expected earnings date for Skye Bioscience is 8 May 2025

Should I buy Skye Bioscience stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions